Orgovyx
NDC 72974-120, relugolix, tablet, film coated, from Sumitomo Pharma America, Inc..
- Product NDC
- 72974-120
- Status
- Listed
- Labeler
- Sumitomo Pharma America, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA214621
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72974-120 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RELUGOLIX120 mg/1
Pharmacologic classes
Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 3A Inducers [MoA]; Decreased GnRH Secretion [PE]; Gonadotropin Releasing Hormone Receptor Antagonist [EPC]; Gonadotropin Releasing Hormone Receptor Antagonists [MoA]; P-Glycoprotein Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72974-120-01 | 72974012001 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-120-01) |
| 72974-120-95 | 72974012095 | 16 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-120-95) |
| 72974-120-97 | 72974012097 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-120-97) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/077a92f6-9f1b-479a-87c7-c92b5db6aa9c
Use it
Look up 72974-120 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72974-120 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72974-120. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.